Black Diamond Therapeutics Company
Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.
Total Funding:
197100000.0
Headquarters:
Cambridge, Massachusetts, United States
Funding Status:
IPO
Employee Number:
11-50
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series C
Last Funding Date:
2019-12-05
Investors Number:
16.0
Founded Date:
2017-01-01
Industry:
End-to-End Drug Development